These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

390 related items for PubMed ID: 10379686

  • 1. Development of resistance and cross-resistance in Pseudomonas aeruginosa exposed to subinhibitory antibiotic concentrations.
    Wu YL, Scott EM, Po AL, Tariq VN.
    APMIS; 1999 Jun; 107(6):585-92. PubMed ID: 10379686
    [Abstract] [Full Text] [Related]

  • 2. Development of antibiotic resistance in Pseudomonas aeruginosa during two decades of antipseudomonal treatment at the Danish CF Center.
    Ciofu O, Giwercman B, Pedersen SS, Høiby N.
    APMIS; 1994 Sep; 102(9):674-80. PubMed ID: 7946270
    [Abstract] [Full Text] [Related]

  • 3. [Synergistic activity between ticarcillin, azlocillin, cefsulodin, ceftazidime and tobramycin or amikacin against Pseudomonas aeruginosa (author's transl)].
    Petit JC, Richard G, Burghoffer B, Daguet GL.
    Pathol Biol (Paris); 1982 Jun; 30(6):426-31. PubMed ID: 6810286
    [Abstract] [Full Text] [Related]

  • 4. [Influence of the inoculum effect on the MIC and MBC of 5 beta-lactams against Pseudomonas aeruginosa].
    Croize J, Le Noc P, Robert J.
    Pathol Biol (Paris); 1984 May; 32(5):412-4. PubMed ID: 6429613
    [Abstract] [Full Text] [Related]

  • 5. Antibiotic treatment of chronic Pseudomonas aeruginosa infection in cystic fibrosis patients.
    Møller NE, Høiby N.
    Scand J Infect Dis Suppl; 1981 May; 29():87-91. PubMed ID: 6458884
    [Abstract] [Full Text] [Related]

  • 6. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.
    Ciofu O.
    APMIS Suppl; 2003 May; (116):1-47. PubMed ID: 14692154
    [Abstract] [Full Text] [Related]

  • 7. [Pseudomonas aeruginosa: acquired in vitro resistance to beta-lactams].
    Thabaut A, Meyran M.
    Pathol Biol (Paris); 1983 May; 31(5):387-91. PubMed ID: 6413939
    [Abstract] [Full Text] [Related]

  • 8. [Comparative activity of ticarcillin-clavulanic acid and various beta-lactams against Pseudomonas maltophilia].
    Monteil H, Jehl F.
    Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):805-8. PubMed ID: 3309818
    [Abstract] [Full Text] [Related]

  • 9. Previous ciprofloxacin exposure is associated with resistance to beta-lactam antibiotics in subsequent Pseudomonas aeruginosa bacteremic isolates.
    López-Dupla M, Martínez JA, Vidal F, Almela M, Soriano A, Marco F, López J, Olona M, Mensa J.
    Am J Infect Control; 2009 Nov; 37(9):753-8. PubMed ID: 19487049
    [Abstract] [Full Text] [Related]

  • 10. Antimicrobial use and Pseudomonas aeruginosa susceptibility profile in a cystic fibrosis centre.
    Manno G, Cruciani M, Romano L, Scapolan S, Mentasti M, Lorini R, Minicucci L.
    Int J Antimicrob Agents; 2005 Mar; 25(3):193-7. PubMed ID: 15737511
    [Abstract] [Full Text] [Related]

  • 11. [Surveillance of Pseudomonas aeruginosa sensitivity to antibiotics in France and distribution of beta-lactam resistance mechanisms: 1998 GERPB study].
    Cavallo JD, Leblanc F, Fabre R.
    Pathol Biol (Paris); 2000 Jun; 48(5):472-7. PubMed ID: 10949844
    [Abstract] [Full Text] [Related]

  • 12. Susceptibility of Pseudomonas aeruginosa to beta-lactam antibiotics.
    Philippon A.
    Chemioterapia; 1985 Dec; 4(6):424-8. PubMed ID: 3938346
    [Abstract] [Full Text] [Related]

  • 13. Ability of azlocillin and tobramycin in combination to delay or prevent resistance development in Pseudomonas aeruginosa.
    Wu YL, Scott EM, Po AL, Tariq VN.
    J Antimicrob Chemother; 1999 Sep; 44(3):389-92. PubMed ID: 10511408
    [Abstract] [Full Text] [Related]

  • 14. Susceptibility patterns and cross-resistance of antibiotics against Pseudomonas aeruginosa isolated from burn patients in the South of Iran.
    Japoni A, Alborzi A, Kalani M, Nasiri J, Hayati M, Farshad S.
    Burns; 2006 May; 32(3):343-7. PubMed ID: 16527415
    [Abstract] [Full Text] [Related]

  • 15. In vitro activity of piperacillin, ticarcillin, mezlocillin, ticarcillin-clavulanic acid, aztreonam, ceftazidime, azlocillin, cefoperazone, and thienamycin against Pseudomonas aeruginosa.
    Greenberg RN, Bollinger MR, Alivisatos MR.
    Clin Ther; 1986 May; 8(6):655-7. PubMed ID: 3098426
    [Abstract] [Full Text] [Related]

  • 16. [Susceptibility of Pseudomonas aeruginosa to aztreonam in comparison to other pseudomonas-active beta-lactam antibiotics and gentamicin].
    Wundt W, Lange KP, Baumgärtner M.
    Arzneimittelforschung; 1985 May; 35(8):1322-5. PubMed ID: 3935123
    [Abstract] [Full Text] [Related]

  • 17. [Sensitivity of Pseudomonas aeruginosa to beta-lactam antibiotics and effects of beta-lactamases].
    Avril JL, Cayla AM, Guist'hau O, Moillo-Batt A.
    Pathol Biol (Paris); 1983 Jun; 31(6):471-5. PubMed ID: 6410345
    [Abstract] [Full Text] [Related]

  • 18. [Sensitivity of Pseudomonas aeruginosa to beta-lactam antibiotics. Apropos of 338 strains isolated at the Regional Hospital Center at Nantes in 1984].
    Reynaud AE, Coude du Foresto B, Espaze EP, Courtieu AL.
    Pathol Biol (Paris); 1987 Sep; 35(7):1023-6. PubMed ID: 3118324
    [Abstract] [Full Text] [Related]

  • 19. [Pseudomonas aeruginosa: bactericidal activity on various beta-lactam resistance phenotypes of 8 antibiotics and 7 combinations].
    Dubrous P, Cavallo JD, Hernandez E, Nordmann P, Fabre R.
    Pathol Biol (Paris); 1997 May; 45(5):433-7. PubMed ID: 9296099
    [Abstract] [Full Text] [Related]

  • 20. [Evolution of antimicrobial resistance against Pseudomonas aeruginosa in a French university hospital between 2002 and 2006].
    Minchella A, Molinari L, Alonso S, Bouziges N, Sotto A, Lavigne JP.
    Pathol Biol (Paris); 2010 Feb; 58(1):1-6. PubMed ID: 19875241
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.